Menu
Back to User profile » Mr Paul J Gomes
Papers published by Mr Paul J Gomes:
Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube®: a randomized clinical trial
Gomes PJ, Abelson MB, Stein L, Viirre E, Villafranca JE, Lasser EC
Journal of Asthma and Allergy 2019, 12:71-81
Published Date: 1 March 2019
Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects
Malhotra RP, Meier E, Torkildsen G, Gomes PJ, Jasek MC
Clinical Ophthalmology 2019, 13:403-413
Published Date: 19 February 2019
Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model
Meier EJ, Torkildsen GL, Gomes PJ, Jasek MC
Clinical Ophthalmology 2018, 12:2617-2628
Published Date: 13 December 2018
Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis
McLaurin E, Bergmann M, Narvekar A, Adewale A, Gomes P, Torkildsen G
Clinical Ophthalmology 2017, 11:1089-1097
Published Date: 8 June 2017
Technical and clinical validation of an environmental exposure unit for ragweed
Gomes PJ, Lane KJ, Angjeli E, Stein L, Abelson MB
Journal of Asthma and Allergy 2016, 9:215-221
Published Date: 14 December 2016
Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
Bergmann MT, Williams JI, Gomes PJ
Clinical Ophthalmology 2014, 8:1495-1505
Published Date: 13 August 2014
Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
Gomes PJ, Ousler GW, Welch DL, Smith LM, Coderre J, Abelson MB
Clinical Ophthalmology 2013, 7:157-165
Published Date: 20 January 2013